Albizia Julibrissin DURAZZ. from Wild Collection – a Multivariate Data Analysis Approach

P. Raab,M. E. Pferschy-Wenzig,H. Liang,F. P. Tu,R. Bauer
DOI: https://doi.org/10.1055/s-0041-1736764
IF: 3.007
2021-01-01
Planta Medica
Abstract:The aim of our research is to investigate traditional herbal medicines to discover new, plant-based alternatives for the treatment of chronic inflammatory diseases. [1] The bark of Albizia julibrissin Durazz., the most valuable candidate emerging from the screening phase, was collected under the guidance of local botanists, in Hubei Province, China, from 9 different locations and 14 different trees. Extraction was performed by successive ultra-sonication of the powdered bark with dichloromethane and methanol, followed by liquid-liquid fractionation of the extracts with dichloromethane, ethyl-acetate, n-butanol and water. LPS- and IFNγ- induced RAW 264.7 macrophages and BV2 microglia cells were used to determine the anti-inflammatory effect of the bark extracts via detection of NO with Griess-reagent, while XTT assay was used to determine respective cytotoxicity. [2] Metabolite profiles were analyzed by means of UHPLC-HRMS analysis. Phytochemical profiles and pharmacological data have been correlated by orthogonal projection to latent structures discriminant analysis (OPLS-DA) to deduce potentially active candidate compounds. Identification of candidate compounds by UHPLC-HRMS dereplication and isolation is in progress.
What problem does this paper attempt to address?